Extensive Line of Anti-Human Protein Antibodies Available

By LabMedica International staff writers
Posted on 24 Sep 2014
A line of antibodies to human blood proteins offers the in vitro diagnostics and life sciences sectors high quality and flexibility in testing for a wide range of blood proteins.

The Binding Site, Inc. (San Diego, CA, USA), a leader in manufacturing of primary antibodies and in discovery, development, manufacture, marketing, and sales of novel immunodiagnostic assays, now offers a comprehensive line of anti-human blood protein antibodies for the improvement of patient care. The availability of this extensive line will benefit the needs and efforts of clinical and life science researchers, medical laboratory professionals, and in vitro diagnostic (IVD) manufacturers alike. By utilization of innovative and patented manufacturing techniques, which yield highly specific antibodies, all in the Anti-Human Protein Antibodies line display the highest degrees of purity, shelf life stability, and lot-to-lot consistency.

Image: A line of antibodies to human blood proteins offers high quality and flexibility in testing for a wide range of blood proteins (Photo courtesy of The Binding Site).

The scope of antibodies available includes those against human acute-phase reactants, coagulation proteins, complement, immunoglobulins, and other blood proteins (i.e., albumin, prealbumin, transferrin, etc.).

All antibodies are available in an unconjugated format which may be conjugated to Biotin, Fluorescein-Isothiocyanate (FITC), Horseradish Peroxidase (HRP), Rhodamine, and others. Plus, a number of these antibodies are available from Binding Site already pre-conjugated to HRP, FITC, or both. These Anti-Human Protein Antibodies are offered in a convenient, operator-oriented standard packaging size of 1.0 mL, with customer distinct and bulk packaging configurations also being available.

Related Links:

The Binding Site



Latest Immunology News